Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)
Clinical trial NCT00112372 · COMPLETED
Trial details
- NCT number
- NCT00112372
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2008-12-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.